Implementation of an extended-infusion piperacillin - tazobactam program at an urban teaching hospital

American Journal of Health-System Pharmacy

Volumn 67, Issue 8, 2010, Pages 622-628

  Xamplas, Renee C ^a   Itokazu, Gail S ^a,b   Glowacki, Robert C ^a,b   Grasso, Amanda E ^a   Caquelin, Clay ^a   Schwartz, David N ^c,d  

^a Jr Hospital of Cook County   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Division of Infectious Disease   (United States)

^d RUSH MEDICAL COLLEGE   (United States)

Author keywords

Beta lactamase inhibitors; Compliance; Dosage schedule; Economics; Hospitals; Medication orders; Penicillins; Physicians; Piperacillin; Prescribing; Protocols; Rational therapy; Tazobactam

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; PENICILLANIC ACID; PIPERACILLIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL PROTOCOL; DOSAGE SCHEDULE COMPARISON; DRUG INFORMATION; DRUG INFUSION; DRUG INTERMITTENT THERAPY; ELECTRONIC MEDICAL RECORD; GRAM NEGATIVE INFECTION; HOSPITAL INFORMATION SYSTEM; HOSPITAL PERSONNEL; HOSPITAL PHARMACY; HUMAN; INFORMATION TECHNOLOGY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MORTALITY; NURSE; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TEACHING HOSPITAL; TEAMWORK; TREATMENT OUTCOME; ECONOMICS; HEALTH CARE QUALITY; INFUSION PUMP; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL ERROR; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; HOSPITALS, TEACHING; HUMANS; INFUSION PUMPS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; MEDICAL ERRORS; PATIENT CARE TEAM; PENICILLANIC ACID; PHARMACY SERVICE, HOSPITAL; PIPERACILLIN; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE;

EID: 77953623722     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp090447     Document Type: Article

References (8)

1. Pakyz AL, MacDougall C, Oinonen M et al. Trends in antibacterial use in US academic health centers: 2002-2006. Arch Intern Med. 2008; 168:2254-60.
2. Zosyn (piperacillin - tazobactam) package insert. Philadelphia: Wyeth Pharmaceuticals Inc.; 2006.
3. Lodise TP, Lomaestro BM, Drusano GL et al. Application of antimicrobial phar macodynamics concepts into clinical practice: focus on beta-lactam antibiotics. Pharmacotherapy. 2006; 26:1320-32.
4. Lodise TP, Lomaestro B, Drusano GL. Piperacillin - tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007; 44:357-63.
5. Patel GW, Patel N, Lat A et al. Outcomes of extended infusion piperacillin/tazobactam for documented gram-negative infections. Diagn Microbiol Infect Dis. 2009; 64:236-40.
6. Grant EM, Kuti JL, Nicolau DP et al. Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital. Pharmacotherapy. 2002; 22:471-83.
7. Drug information for the health care professional. 26th ed. Greenwood Village, CO: Thomson Micromedex; 2006.
8. Wisniewski MF, Kieszkowski P, Zagorski BM et al. Development of a clinical data warehouse for hospital infection control. J Am Med Inform Assoc. 2003; 10:454-62.